PeerVoice Clinical Pharmacology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.


Incretin Effect 101: Why We Need to Look Beyond GLP-1 in T2DM

Visit to view the entire programme with slides. After completing “Incretin Effect 101: Why We Need to Look Beyond GLP-1 in T2DM”, participants will be able to: Discuss emerging clinical evidence for incretin therapies for type 2 diabetes (T2DM) and how this data may impact future management strategies; Describe the function of incretin hormones and their role in the pathogenesis of T2DM; Recognise the benefits of incretin therapies beyond glycaemic control in patients with T2DM.


 2021-11-04  22m